Current Clinical Trials

Glaukos - Clinical Study

The objective of this study is to evaluate the safety and IOP-lowering efficacy of administering an iDose TR (travoprost intraocular implant) in conjunction with the placement of iStent infinite trabecular bypass system compared with placement of iStent infinite trabecular bypass system alone, in subjects with glaucoma or high eye pressure
 
You may be a possible candidate for this study if you meet the following criteria:
  • Male or female, 18 years of age or older
  • Have a diagnosis of glaucoma or high eye pressure
  • Are on 0 to 2 ocular hypotensive medications
  • No prior incisional glaucoma surgery
The expected study duration is approximately 12 months. You will be reimbursed for you time and travel expenses to attend study visits, up to $1050

 

Sponsor: Glaukos

Spyglass-Tigris Study

Evaluation of the Bimatoprost Implant System Used in Combination With the SpyGlass Intraocular Lens Compared to Timolol Ophthalmic Solution (Tigris)

  • Adult males or females ≥ 22 years of age
  • Have mild to moderate open angle glaucoma (i.e., primary, pseudoexfoliative, or pigmentary) or Ocular Hypertension
  • Planned removal of cataract

Participation includes exams to asses your eye health, follow-up care for up to 3 years, and stipend up to $2125

Sponsor: Spyglass Pharma

 

ELIOS - Clinical Trial

Excimer laser treatment for mild to moderate glaucoma patients. The ELIOS Procedure may help reduce or eliminate the need for glaucoma medications in some patients.

You may be eligible to participate in a clinical study for ELIOS™ Technology. To qualify, you must:

  • Be at least 45 years old
  • Be currently using glaucoma medication or have previous history of laser treatment for glaucoma
  • Participation includes exams to assess your eye health, follow-up care for up to 1 year, and reimbursement of up to $900 for costs associated with time and travel

Sponsor: ELIOS Vision, Inc

iSTAR - Clinical Trial

A Prospective, Multicenter Masked Clinical Trial to Evaluate the Safety and Effectiveness of the MINIject CS627 Implant in Subjects With Open Angle Glaucoma

Do you have open angle glaucoma?

If you have been told by your eye doctor that you have glaucoma, you may be able to participate in a clinical study. To qualify you must:

  • Be 46 years of age or older
  • Be diagnosed with Open Angle Glaucoma (POAG)
  • Have had cataract surgery
  • Meet all other study-related criteria

The MINIijectTM implant is an investigational medical device made of 100% medical grade silicone designed to lower intraocular pressure (IOP) in primary open angle glaucoma. The MINIijectTM procedure is designed to be less invasive than traditional glaucoma surgery and is performed using microsurgical incisions.

Sponsor: iSTAR Medical

Sign Up for Clinical Trials

If you're interested in participating in one of these studies, please fill out the form below: